三友医疗拟以2000万元增资椎元医学

Group 1 - The core point of the article is that Sanyou Medical (688085) plans to invest 20 million yuan in Zhuyuan Medical Technology (Shanghai) Co., Ltd., acquiring a 9.0909% stake in the company [1] - Zhuyuan Medical focuses on innovative cell therapy for intervertebral disc degeneration, with its main product "FibroCell-001" aimed at improving cell activity and microenvironment within the disc to alleviate pain and maintain disc height [1] - The investment is intended to expand Sanyou Medical's business, as the product line of Zhuyuan Medical aligns with Sanyou's existing business, enhancing its overall competitiveness and value [1]